Serum adiponectin and leptin levels are useful markers for prostate cancer screening after adjustments for age, obesity-related factors, and prostate volume

Minerva Urologica e Nefrologica

Volumn 64, Issue 3, 2012, Pages 199-208

  Nishimura, K ^a   Soda, T ^a   Nakazawa, S ^a   Yamanaka, K ^a   Hirai, T ^a   Kishikawa, H ^a   Ichikawa, Y ^a  

^a Hyogo Prefectural Nishinomiya Hospital   (Japan)

Author keywords

Adiponectin; Leptin; Obesity; Prostatic neoplasms

Indexed keywords

ADIPONECTIN; LEPTIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EARLY DETECTION OF CANCER; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84869208388     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
2. Loud Håheim L, Wisløff TF, Holme I, Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 2006;164:769-74. (Pubitemid 44522081)
3. Putnam SD, Cerhan JR, Parker AS, Bianchi GD, Wallace RB, Cantor KP et al. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 2000;10:361-9. (Pubitemid 30645790)
4. Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 2006;164:1094-102. (Pubitemid 44851745)
5. Porter MP, Stanford JL. Obesity and the risk of prostate cancer. Prostate 2005,62:316-21. (Pubitemid 40224137)
6. Buschemeyer WC 3rd, Freedland SJ. Obesity and prostate cancer:epidemiology and clinical implications. Eur Urol 2007;52:331-43. (Pubitemid 46963472)
7. Paz-Filho G, Lim EL, Wong ML, Licinio J. Associations between adipokines and obesity-related cancer. Frontiers in Bioscience 2011;16:1634-50.
8. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin - the classical, resistin - the controversial, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005;19:525-46. (Pubitemid 41819217)
9. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-51. (Pubitemid 40686653)
10. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22.
11. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005;65:1168-72. (Pubitemid 40824911)
12. Freedland SJ, Sokoli LJ, Platz EA, Mangold LA, Bruzek DJ, Mohr P et al. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol 2005;174:1266-70. (Pubitemid 41318699)
13. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J et al. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004;59:268-74. (Pubitemid 38509759)
14. Saglam K, Aydur E, Yilmaz M, Göktax S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol 2003;169:1308-11. (Pubitemid 36323773)
15. Bub JD, Miyazaki T, Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 2006;340:1158-66. (Pubitemid 43083400)
16. Onuma M, Bub JD, Rummel TL, Iwamato Y. Prostate cancer cell-adipocyte interaction:leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem 2003;278:42660-7. (Pubitemid 37310540)
17. Baillargeon J, Plats EA, Rose DP, Pollock BH, Ankerst DP, Haffner S et al. Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev 2006;15:1331-5. (Pubitemid 44125290)
18. Gannagé-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 2006;155:167-76. (Pubitemid 44103386)
19. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 2005;62:114-8. (Pubitemid 40175291)
20. Isidori AM, Strollo F, Moré M, Caprio M, Aversa A, Moretti C et al. Leptin and aging:correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000;85:1954-62. (Pubitemid 32269305)
21. Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Taelenis S, Giannopoulos A et al. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancera case control study. Cancer Epidemiol Biomarkers Prev 2007;16:308-13. (Pubitemid 46383351)
22. Using AW, Chua S Jr, Gao YT, Genizschein E, Chang L, Deng J et al. Prostate cancer risk and serum levels of insulin and leptin:a population-based study. J Natl Cancer Inst 2001;93:783-9. (Pubitemid 32514802)
23. Chang S, Hursting SD, Contois JH, Strom SS, Yamamura Y, Babaian RJ et al. Leptin and prostate cancer. Prostate 2001;46:62-7. (Pubitemid 32157777)
24. Fowke JH, Matthews CM, Buchowski MS, Signorello LB, Chang SS, Cookson MS et al. Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. Prostate Cancer and Prostatic Diseases 2008;11:264-9.
25. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004;94:e27-e31.
26. Seino Y, Hirose H, Saito I, Itoh H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome:a population-based 6-year follow-up study in Japanese men. Metabolism 2009;58:355-60.
27. Zaytoun OM, Jones JS. Prostate cancer detection after a negative prostate biopsy:lessons learnt in the Cleveland Clinic experience. Int J Urol 2011;18:557-68.
28. Dunkley AJ, Stone MA, Patel N, Davies MJ, Khunti K. Waist circumference measurement:knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. Fam Pract 2009;26:365-71.